BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25400040)

  • 1. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
    Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY
    Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.
    Chen Y; Li HH; Fu J; Wang XF; Ren YB; Dong LW; Tang SH; Liu SQ; Wu MC; Wang HY
    Cell Res; 2007 Dec; 17(12):1020-9. PubMed ID: 18040287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity.
    Dai RY; Chen Y; Fu J; Dong LW; Ren YB; Yang GZ; Qian YW; Cao J; Tang SH; Yang SL; Wang HY
    Cell Res; 2009 Nov; 19(11):1243-57. PubMed ID: 19736567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.
    Dong LW; Yang GZ; Pan YF; Chen Y; Tan YX; Dai RY; Ren YB; Fu J; Wang HY
    Cell Res; 2011 Aug; 21(8):1248-61. PubMed ID: 21691299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.
    Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY
    Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular bridge between RelA/p65 and NF-κB target genes via histone acetyltransferase TIP60 cofactor.
    Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
    J Biol Chem; 2012 Mar; 287(10):7780-91. PubMed ID: 22249179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
    Higashitsuji H; Higashitsuji H; Liu Y; Masuda T; Fujita T; Abdel-Aziz HI; Kongkham S; Dawson S; John Mayer R; Itoh Y; Sakurai T; Itoh K; Fujita J
    Biochem Biophys Res Commun; 2007 Nov; 363(3):879-84. PubMed ID: 17904523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A.
    Neuhöfer P; Liang S; Einwächter H; Schwerdtfeger C; Wartmann T; Treiber M; Zhang H; Schulz HU; Dlubatz K; Lesina M; Diakopoulos KN; Wörmann S; Halangk W; Witt H; Schmid RM; Algül H
    Gastroenterology; 2013 Jan; 144(1):192-201. PubMed ID: 23041330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional cross-talk between p73beta and NF-kappaB mediated by p300.
    Ryou SM; Kang KH; Jeong MH; Kim JW; An JH; Lee SY; Jang S; Song PI; Choi KH
    Biochem Biophys Res Commun; 2006 Jun; 345(2):623-30. PubMed ID: 16696941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
    Hoberg JE; Popko AE; Ramsey CS; Mayo MW
    Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
    Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
    Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
    Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
    PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells.
    Zhang NN; Sun QS; Chen Z; Liu F; Jiang YY
    Mol Cell Biochem; 2013 Jan; 372(1-2):57-64. PubMed ID: 23054188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB RelA phosphorylation regulates RelA acetylation.
    Chen LF; Williams SA; Mu Y; Nakano H; Duerr JM; Buckbinder L; Greene WC
    Mol Cell Biol; 2005 Sep; 25(18):7966-75. PubMed ID: 16135789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-associated box-associated protein 1 negatively regulates TNF-α-induced NF-κB transcriptional activity by influencing the interactions among STAT3, p300, and NF-κB/p65.
    Kamitani S; Togi S; Ikeda O; Nakasuji M; Sakauchi A; Sekine Y; Muromoto R; Oritani K; Matsuda T
    J Immunol; 2011 Sep; 187(5):2476-83. PubMed ID: 21810609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
    Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
    Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
    Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
    J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.